Related content

Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence on the Protective Role of High-Density Lipoprotein (HDL) in HIV-Infected Individuals

By  

Current Vascular Pharmacology, Vol. 13, Iss. 2, 2015-01 ,pp. : 167-172

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 9, 2015-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)

By Zhao X.-Q.   Morse J.S.   Dowdy A.A.   Heise N.   DeAngelis D.   Frohlich J.   Chait A.   Albers J.J.   Brown B.G.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

Expression and hormonal regulation of the high-density lipoprotein (HDL) receptor scavenger receptor class B type I messenger ribonucleic acid in the rat ovary

By McLean Mark   Sandhoff Todd  

Endocrine Journal, Vol. 9, Iss. 3, 1998-12 ,pp. : 243-252

Humana Press, Inc

Access to resources Recommend Favorite